Optase

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for use as a lubricant to prevent further irritation of the eye. It may also be utilized as a protectant against additional irritation. Additionally, this drug is indicated for the relief of dryness of the eye.

Dosage and Administration

Healthcare professionals are advised to follow the outlined procedures for the administration of the medication. Prior to use, it is essential to wash hands thoroughly to maintain hygiene.

The medication is provided in single-dose containers, which are packaged in an aluminium pouch. To access the medication, open the pouch and carefully pull out the strip containing the single-dose containers. Remove one container from the strip while ensuring that the remaining containers are placed back into the pouch, which should then be securely closed by folding the edge over.

To open the single-dose container, twist and pull the tab to remove it. It is crucial to avoid touching the tip of the container after it has been opened to prevent contamination. The recommended dosage is to instill one or two drops into the affected eyes as needed. The solution should be used immediately after opening, and any remaining solution must not be reused. Discard any unused portion of the solution following administration to ensure safety and efficacy.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

For external use only, this product must be handled with care to prevent contamination. Healthcare professionals should instruct patients to avoid touching the tip of the container to any surface. If the solution changes color or becomes cloudy, it should not be used. Additionally, any single-dose container that is damaged or punctured must be discarded and not used.

It is essential to allow a minimum of 15 minutes between applications of other ophthalmic medications to ensure proper absorption and efficacy. Once opened, the solution should be used immediately and not reused; any remaining solution must be discarded after use. Patients should be advised not to use the product if they are sensitive to any of its ingredients or if the expiry date indicated on the packaging has passed.

General precautions include keeping the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a poison control center is recommended.

Side Effects

Patients should be aware of several important warnings associated with the use of this product. It is intended for external use only, and to prevent contamination, patients must avoid touching the tip of the container to any surface. If the solution changes color or becomes cloudy, it should not be used. Additionally, patients should not use a damaged or punctured single-dose container.

To ensure safety and efficacy, it is recommended that patients wait at least 15 minutes between applications of other ophthalmic medications. The solution should be used immediately once opened, and any remaining solution must be discarded after use; it is not to be reused. Patients with known sensitivities to any of the ingredients should refrain from using the product. Furthermore, it is crucial to adhere to the expiry date indicated on the packaging, as using the product after this date is not advised.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Optase (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a poison control center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Continuous monitoring of vital signs and clinical status is essential. If symptoms of overdosage are observed, appropriate interventions should be implemented based on the patient's condition.

Healthcare professionals should also consider contacting a poison control center or a medical toxicologist for guidance on management strategies tailored to the specific situation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a poison control center immediately. It is essential for patients to understand the importance of these precautions to ensure their safety and the safety of others.

Storage and Handling

The product is available in various package configurations, with specific NDC numbers assigned for identification. Currently, there are no specific storage instructions or handling details provided. It is advisable for healthcare professionals to follow standard storage practices for pharmaceutical products, ensuring that they are kept in a suitable environment to maintain product integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Optase, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)